Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Private Equity

Scythian Biosciences Corp. Announces Andy Defrancesco As A New Director

by investorintel.com posted 2months ago 36 views
September 4, 2018 (Source) — Scythian Biosciences Corp. (the “Company” or “Scythian”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) announced today that it has appointed Andrew DeFrancesco to the Board of Directors effective September 4, 2018. Mr. DeFrancesco has over 26 years of capital markets experience, from senior positions at some of Canada’s most established independent investment firms in trading, sales and investment banking, to establishing first mover status as the founder and co-founder of a number of North American small and mid-capital companies and sectors.